लोड हो रहा है...
Correlating EGFR Expression with Receptor-Binding Properties and Internalization of (64)Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines
The anti–epidermal growth factor receptor (anti-EGFR) antibody cetuximab is clinically approved for the treatment of EGFR-expressing metastatic colorectal cancer and advanced head and neck cancer. Overexpression of EGFR has also been found in more than 70% of carcinomas of the cervix. The overall go...
में बचाया:
| में प्रकाशित: | J Nucl Med |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2008
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4277815/ https://ncbi.nlm.nih.gov/pubmed/18703609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.108.052316 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|